Shishuo Sun

629 total citations
18 papers, 467 citations indexed

About

Shishuo Sun is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shishuo Sun has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Shishuo Sun's work include CAR-T cell therapy research (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shishuo Sun is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Shishuo Sun collaborates with scholars based in China, United States and Czechia. Shishuo Sun's co-authors include Yizhou Yao, Xiong Su, Qing Zhang, Junnian Zheng, Xiaoge Gao, Nada A. Abumrad, Yang Yu, Huiyu Wang, Yuqing Zhou and Tong Hu and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Journal of Lipid Research.

In The Last Decade

Shishuo Sun

18 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shishuo Sun China 13 230 156 122 65 60 18 467
Huimin Du China 13 189 0.8× 153 1.0× 127 1.0× 54 0.8× 107 1.8× 30 484
Mehdi Chaib United States 9 188 0.8× 114 0.7× 206 1.7× 27 0.4× 66 1.1× 17 445
Yuchen Zhang China 12 295 1.3× 164 1.1× 72 0.6× 52 0.8× 125 2.1× 40 585
Han Qiao China 14 276 1.2× 76 0.5× 86 0.7× 53 0.8× 130 2.2× 38 595
Yi-Ju Lee Taiwan 11 207 0.9× 128 0.8× 87 0.7× 29 0.4× 43 0.7× 13 437
Zhitao Gao China 10 150 0.7× 133 0.9× 134 1.1× 51 0.8× 53 0.9× 25 461
Liangzhi Wen China 11 300 1.3× 95 0.6× 64 0.5× 42 0.6× 124 2.1× 26 521
Yuanyuan Yu China 13 265 1.2× 79 0.5× 55 0.5× 50 0.8× 65 1.1× 25 470

Countries citing papers authored by Shishuo Sun

Since Specialization
Citations

This map shows the geographic impact of Shishuo Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shishuo Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shishuo Sun more than expected).

Fields of papers citing papers by Shishuo Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shishuo Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shishuo Sun. The network helps show where Shishuo Sun may publish in the future.

Co-authorship network of co-authors of Shishuo Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shishuo Sun. A scholar is included among the top collaborators of Shishuo Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shishuo Sun. Shishuo Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Qihong, et al.. (2024). Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy. Biochemical Pharmacology. 227. 116439–116439. 4 indexed citations
2.
Li, Qihong, Lin Yang, Shuyu Li, et al.. (2024). Cabozantinib enhances CAIX specific CAR-T cells against renal cancer by improving effector functions and augmenting tumor immune microenvironment. Biochemical and Biophysical Research Communications. 734. 150781–150781. 2 indexed citations
3.
Guo, Ziheng, Jing Xu, Xiaoting Sun, et al.. (2024). Tumor angiogenesis and anti-angiogenic therapy. Chinese Medical Journal. 137(17). 2043–2051. 12 indexed citations
4.
Sun, Shishuo, et al.. (2023). Herpes Virus Entry Mediator Costimulation Signaling Enhances CAR T-cell Efficacy Against Solid Tumors Through Metabolic Reprogramming. Cancer Immunology Research. 11(4). 515–529. 12 indexed citations
5.
Sun, Shishuo, Qihong Li, Guopeng Zhang, et al.. (2023). PA suppresses antitumor immunity of T cells by disturbing mitochondrial activity through Akt/mTOR-mediated Ca2+ flux. Cancer Letters. 581. 216511–216511. 12 indexed citations
6.
Gao, Xiaoge, Wei Zhang, Jiwei Zheng, et al.. (2023). Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity. BMC Cancer. 23(1). 154–154. 1 indexed citations
7.
Wang, Yifei, Yuxiao Zhao, Chao Huang, et al.. (2023). DHA attenuates CAR-T cell efficacy through aggravating exhaustion and inducing apoptosis. Biologia. 78(4). 1141–1152. 1 indexed citations
8.
Yao, Yizhou, Shishuo Sun, Diyuan Zhou, et al.. (2022). Roux-en-Y reconstruction alleviates radical gastrectomy-induced colitis via down-regulation of the butyrate/NLRP3 signaling pathway. EBioMedicine. 86. 104347–104347. 20 indexed citations
9.
Zhang, Xiaokang, Shishuo Sun, Yifan Yuan, et al.. (2022). Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs. Journal of Cancer Research and Clinical Oncology. 148(12). 3511–3520. 19 indexed citations
10.
Sun, Shishuo, Yizhou Yao, Chao Huang, et al.. (2022). CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization. Cellular Immunology. 372. 104475–104475. 29 indexed citations
11.
Shao, Xinyu, Shishuo Sun, Yuqing Zhou, et al.. (2021). Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis. Cancer Letters. 523. 170–181. 97 indexed citations
12.
Lü, Mengmeng, Xiaokang Zhang, Xiaoge Gao, et al.. (2021). Lenvatinib enhances T cell immunity and the efficacy of adoptive chimeric antigen receptor-modified T cells by decreasing myeloid-derived suppressor cells in cancer. Pharmacological Research. 174. 105829–105829. 35 indexed citations
13.
Liu, Hongyan, Shishuo Sun, Gang Wang, et al.. (2021). Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity. Frontiers in Oncology. 11. 663517–663517. 16 indexed citations
14.
Yao, Yizhou, Xiaoqin Yang, Liang Sun, et al.. (2019). Fatty acid 2-hydroxylation inhibits tumor growth and increases sensitivity to cisplatin in gastric cancer. EBioMedicine. 41. 256–267. 49 indexed citations
15.
Zhang, Qing, Hongyan Liu, Hanhan Wang, et al.. (2019). Lenvatinib promotes antitumor immunity by enhancing the tumor infiltration and activation of NK cells.. PubMed. 9(7). 1382–1395. 35 indexed citations
16.
Zhang, Qing, Jiage Ding, Shishuo Sun, et al.. (2019). Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.. PubMed. 9(11). 2379–2396. 41 indexed citations
17.
Sun, Shishuo, et al.. (2017). Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes. Journal of Biological Chemistry. 293(7). 2383–2394. 25 indexed citations
18.
Hu, Xiaoqian, Vincenza Cifarelli, Shishuo Sun, et al.. (2016). Major role of adipocyte prostaglandin E2 in lipolysis-induced macrophage recruitment. Journal of Lipid Research. 57(4). 663–673. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huimin Du Breakdown of academic impact, for papers by Mehdi Chaib Breakdown of academic impact, for papers by Yuchen Zhang Breakdown of academic impact, for papers by Han Qiao Breakdown of academic impact, for papers by Yi-Ju Lee Breakdown of academic impact, for papers by Zhitao Gao Breakdown of academic impact, for papers by Liangzhi Wen Breakdown of academic impact, for papers by Yuanyuan Yu
Rankless by CCL
2026